Skip to content

Clinical trials

Phase 2 Lung Diseases trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 2 Status: Unknown status Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20161
20171
20181
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sichuan Cancer Hospital and Research Institute3
Jiangsu HengRui Medicine Co., Ltd.1
Protalix1
Royal Marsden NHS Foundation Trust1
University Hospital, Clermont-Ferrand1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases7
Respiratory Tract Diseases4
Carcinoma, Non-Small-Cell Lung3
Thoracic Neoplasms3
Neoplasms2
Bronchial Neoplasms1
Carcinoma, Bronchogenic1
Cystic Fibrosis1
Digestive System Diseases1
Disease1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.